Gene-Edited Foods in 2026: What’s on the Market, How CRISPR Crops Are Regulated, and How They’re Labeled
sold in the U.S., later
withdrawn
SECURE rule for gene-edited
and GE plants
gene-edited plants
take effect
A decade ago, headlines warned that Monsanto’s $125 million investment in new genetic technologies would flood supermarkets with genetically modified strawberries, wheat, and other foods. The technology at the center of those deals was gene editing, particularly CRISPR, which lets scientists make precise changes to a plant’s own DNA. Monsanto, now part of Bayer, invested in startups such as Pairwise to develop gene-edited crops.
The flood has not arrived. As of 2026, only a handful of gene-edited foods have reached consumers anywhere in the world, and even the first CRISPR vegetable sold in the United States was withdrawn after less than a year. At the same time, regulators in the United States, Europe, and elsewhere have been rewriting their rules. This article explains what gene editing is, how it differs from older genetic engineering, which products are on or near the market, how they are regulated and labeled, and what questions remain.
Key takeaways
Gene editing tools such as CRISPR make targeted changes to an organism’s own DNA, often small deletions or edits that could in principle arise through conventional breeding. Traditional GMOs typically add genes from other species.
Few gene-edited foods have reached consumers. Pairwise launched less-pungent mustard greens in the U.S. in 2023 but withdrew them by early 2024; it has obtained USDA confirmations for seedless and thornless berry traits.
A federal court vacated USDA’s 2020 SECURE rule in December 2024, returning the agency to its older framework while it develops a replacement rule, expected in 2026.
The EU adopted a regulation in June 2026 that treats many gene-edited plants (NGT category 1) like conventional plants without GMO labeling, applying from July 2028; organic production will continue to exclude them.
What Gene Editing Is
Genetic engineering in the familiar sense, the technology behind most GM crops grown today, usually involves inserting genes into a plant, often from bacteria or other species, to give it new traits such as insect resistance or herbicide tolerance. Gene editing uses molecular tools to make targeted changes at specific locations in a plant’s existing DNA. The most widely used tool, CRISPR-Cas9, acts like molecular scissors guided to a chosen DNA sequence, where it cuts; the plant’s own repair processes then create small changes, such as deleting a few DNA letters to switch off a gene. Newer techniques, such as base editing and prime editing, can change individual DNA letters without cutting both strands.
Many gene-edited plants carry no foreign DNA in the final product, because the editing machinery can be removed through breeding. Their changes may be indistinguishable from mutations that occur naturally or through conventional breeding methods, including mutagenesis using radiation or chemicals, which has been used since the mid-20th century to create many crop varieties. A 2021 review in Cell by plant scientist Caixia Gao describes how genome editing is being applied to improve yield, quality, disease resistance, and stress tolerance in crops.
Whether these differences should change how gene-edited foods are regulated and labeled is the central policy question. Supporters argue that products, not processes, should determine oversight. Critics argue that gene editing can produce unintended changes and that consumers have a right to know how their food was made.
What Has Reached the Market
Despite years of predictions, only a small number of gene-edited foods have been sold to consumers.
| Product | Trait | Where and when | Status |
|---|---|---|---|
| High-oleic soybean oil | Healthier fatty acid profile, no trans fats | United States, 2019 | Early commercial example; limited scale |
| High-GABA tomato | More gamma-aminobutyric acid | Japan, 2021 | Sold in Japan |
| Edited sea bream and pufferfish | Faster growth, more muscle | Japan, 2021 | Sold in Japan |
| Mustard greens (Conscious Greens) | Less pungent taste | United States, 2023 | Withdrawn by early 2024; licensed to Bayer |
| Blackberries | Seedless, thornless, higher yield | USDA confirmations 2024 | In development; limited sales abroad |
| Non-browning banana | Reduced browning and waste | Philippines regulatory clearance | Moving toward market |
The mustard greens story illustrates the challenges. Pairwise launched its less-bitter greens in the United States in 2023 through a foodservice distributor, but according to a June 2025 report by the Canadian Biotechnology Action Network, a group critical of gene editing, the company had removed them from the market by February 2024 to focus on other crops, and licensed the greens to Bayer, which had not set a launch date as of mid-2025. Pairwise announced in January 2024 that it had received USDA confirmations for 19 berry traits, including seedless, thornless, and higher-yielding blackberries and black raspberries, but bringing new fruit varieties to large-scale production takes years.
How the United States Regulates Gene-Edited Crops
In the U.S., agricultural biotechnology is overseen by USDA, the EPA, and the FDA under the Coordinated Framework, described in our article on how the U.S. decided to regulate GMOs. In 2020, USDA’s SECURE rule created exemptions for many gene-edited plants with changes that could be achieved through conventional breeding, which is how Pairwise’s berry traits were confirmed as exempt.
That framework was overturned. As the National Law Review reported, on December 2, 2024, a federal district court in California, ruling in a case brought by farm and conservation groups, vacated the SECURE rule and remanded it to USDA, finding among other things that the agency had acted arbitrarily in implementing its conventional-breeding exemptions. Exemption confirmations issued before the ruling remained valid. A March 2026 Congressional Research Service report notes that USDA now operates under its pre-2020 regulations while it develops a replacement, an anticipated interim final rule titled “Regaining Lost Efficiencies for Products of Biotechnology,” with publication projected for 2026. The FDA continues to encourage voluntary consultations on foods from new plant varieties, and the EPA regulates plants engineered to produce pesticidal substances.
For labeling, USDA’s bioengineered food disclosure standard applies to foods with genetic modifications that could not be obtained through conventional breeding or found in nature, so many gene-edited foods may not require a BE disclosure. Our article on the fight over GMO labels explains the standard and a 2025 court ruling that requires USDA to revise it.
Europe’s New Approach
The European Union has long had some of the world’s strictest rules on genetically modified organisms, and a 2018 European Court of Justice ruling held that gene-edited organisms fell under those rules. After years of debate, the EU adopted a new regulation. According to the feed certification organization GMP+ International, the European Parliament and Council adopted Regulation (EU) 2026/1388 on plants obtained through certain new genomic techniques on June 17, 2026; it was published on June 26, 2026, and will apply from July 17, 2028. The regulation creates two categories: NGT category 1 plants, considered equivalent to conventionally bred plants, will not be classified as GMOs and will not require GMO labeling, while category 2 plants will remain subject to authorization and labeling. Seeds of category 1 plants will be labeled, and the use of NGT plants in organic production remains prohibited.
Supporters argue the rules will help European farmers adapt to climate change and reduce pesticide use. Critics, including many organic and consumer groups, say the lack of consumer labeling for category 1 products reduces transparency and will complicate supply chains for GMO-free and organic products.
Conventional Breeding Already Changes DNA
Discussions of gene editing often overlook how much conventional breeding alters plant genomes. Crossing different varieties shuffles thousands of genes. Since the mid-20th century, breeders have also used mutagenesis, exposing seeds to radiation or chemicals to create random mutations, then selecting useful ones. Many familiar varieties came from such methods, including the Rio Red grapefruit and numerous varieties of wheat, rice, and barley. These varieties are not regulated as GMOs and can be grown organically. Supporters of gene editing argue that targeted edits are more precise than random mutagenesis; critics respond that the long history of mutagenesis does not automatically establish the safety of new techniques, and that the scale and speed of gene editing raise new questions.
Potential Benefits Under Study
Researchers are using gene editing to pursue traits that could benefit farmers, consumers, and the environment: resistance to plant diseases that otherwise require fungicides, tolerance of drought and heat, reduced allergens or toxins, longer shelf life that cuts food waste, improved nutritional profiles, and crops better suited to mechanical harvesting. Many of these traits could in principle be achieved through conventional breeding but would take many more years. Whether these benefits materialize depends on research success, regulation, costs, and consumer acceptance.
Patents and Who Benefits
CRISPR technologies are covered by patents held by universities and companies, and access is typically licensed. Large seed companies, including Bayer and Corteva, have secured licenses and partnerships, raising concerns similar to those discussed in our article on consolidation in the seed and pesticide industry. At the same time, gene editing is cheaper and simpler than older genetic engineering, which has allowed universities, public breeding programs, and small companies to develop products, potentially broadening who can innovate. How patents and regulations are structured will influence whether gene editing reinforces or reduces concentration in agriculture.
Can Gene-Edited Foods Be Detected?
Detecting gene-edited products is a practical challenge for labeling and traceability. Traditional GMOs carry foreign DNA sequences that laboratory tests can find. A small edit that matches a naturally occurring variation may be impossible to distinguish from a conventional mutation without knowing exactly what to look for. Regulators and certifiers therefore rely heavily on documentation and supply chain records, which is part of why the EU’s new regulation includes labeling for category 1 seeds and a public database, and why organic and non-GMO programs emphasize traceability.
Other Countries
Many countries have moved toward lighter regulation of gene-edited plants without foreign DNA. Argentina pioneered a case-by-case approach in 2015, determining whether each product counts as a GMO. Japan allows notification rather than full GMO assessment for certain edited foods, which enabled its early products. In England, the Precision Breeding Act 2023 created a separate regime for precision-bred plants, with implementing regulations for plants taking effect in November 2025. Canada has exempted many gene-edited plants from its novel-food requirements. China and India have also created pathways for some gene-edited crops. These shifts mean that gene-edited foods may enter international trade under different rules in different markets.
Safety Questions
Scientific bodies generally consider that the safety of a food depends on its characteristics, not the method used to produce it. The National Academies of Sciences, Engineering, and Medicine recommended in 2016 that regulation focus on the traits of new varieties rather than the breeding process. Gene editing can, however, cause unintended changes, including edits at similar DNA sequences elsewhere in the genome, known as off-target effects, or larger rearrangements at the target site. Plant breeders typically screen and backcross edited plants to remove unwanted changes, and conventional breeding also introduces many genetic changes. Critics argue that regulators should still require case-by-case assessment and that long-term effects deserve study. Most experts agree that the specific trait, for example, changes to nutrients, allergens, or toxins, matters more for safety than how it was created.
Gene-Edited Animals
Gene editing in livestock has advanced more slowly. In the United States, the FDA regulates intentional genomic alterations in animals and has made low-risk determinations for some products, such as cattle edited to have short, slick hair coats that help them tolerate heat. Disease-resistance traits, such as pigs edited to resist porcine reproductive and respiratory syndrome, a costly viral disease, have also moved through regulatory review. Animal welfare and public acceptance questions are prominent in debates over edited animals.
How Organic and Non-GMO Standards Treat Gene Editing
Shoppers who wish to avoid gene-edited foods have two main options. USDA organic standards prohibit genetic engineering as an excluded method, and the National Organic Standards Board has recommended that gene editing be treated as excluded. The Non-GMO Project also considers gene-edited organisms to be GMOs under its standard. Because many gene-edited foods may not carry a BE disclosure in the United States, or GMO labels in Europe once the new rules apply, these certifications are the most reliable way to avoid them.
What to Watch
USDA’s replacement rule. The anticipated interim final rule will determine how gene-edited plants are reviewed in the U.S.
EU implementation. Rules for detecting and tracing NGT plants and products will matter for trade and organic supply chains before the 2028 application date.
New products. Seedless berries, non-browning produce, disease-resistant crops, and climate-adapted varieties are in development.
Consumer response. Whether shoppers accept or avoid gene-edited foods will shape how quickly they spread.
What Consumers Think
Surveys of consumer attitudes toward gene-edited foods show mixed and often uncertain views. Many people are unfamiliar with gene editing or do not distinguish it from older genetic engineering. Some studies suggest consumers are more accepting when gene editing provides clear benefits to them, such as improved nutrition, reduced pesticide use, or less food waste, than when benefits accrue mainly to producers. Trust in regulators and transparency about how products are made also influence acceptance. Retailers and food companies have been cautious about promoting gene-edited ingredients, partly because of uncertainty about consumer reactions.
Organic Farmers’ Concerns
Organic farmers and certifiers have particular concerns. Because organic standards prohibit gene editing, organic producers must avoid gene-edited seeds and prevent contamination through cross-pollination or mixing in storage and transport. If gene-edited varieties are not labeled or tracked, organic farmers may find it harder to verify that their seeds and inputs are free of them. These concerns echo long-standing issues with traditional GM crops, discussed in our article on the costs organic farmers bear from GMO contamination, and they shaped the EU’s decision to require labeling of category 1 seeds and maintain a public database.
Key Terms
Gene editing: Techniques that make targeted changes to an organism’s own DNA.
CRISPR-Cas9: The most widely used gene-editing tool, which cuts DNA at a chosen location.
Transgenic: Containing genes transferred from another species, typical of traditional GMOs.
Mutagenesis: Creating random mutations with radiation or chemicals, used in conventional breeding since the mid-20th century.
SECURE rule: USDA’s 2020 biotechnology regulation, vacated by a court in December 2024.
NGT: New genomic techniques, the EU’s term for gene editing and related methods.
The Bottom Line
Gene editing has not flooded supermarkets as headlines once predicted. Only a few gene-edited foods have reached consumers, and the first CRISPR vegetable sold in the United States was withdrawn. Regulation is in flux: USDA’s 2020 rule was vacated in 2024 and a replacement is pending, while the EU adopted rules in 2026 that will treat many edited plants like conventional crops from 2028. Gene-edited foods may not carry GMO or bioengineered labels, so shoppers who want to avoid them can rely on organic and Non-GMO Project certification. Whether gene editing delivers on its promises will depend on the traits developed, how they are regulated, and how much consumers trust the process.
Questions to Ask About a Gene-Edited Product
When a new gene-edited food is announced, a few questions can help consumers evaluate it: What trait was changed, and who benefits, consumers, farmers, or processors? Does the edit involve any foreign DNA? Did regulators review it, and how? Has the company published information about its testing? Is it labeled, and if not, how can consumers find out whether they are buying it? Answers vary by product and country, and transparency from developers can help build informed public discussion.
Gene Editing and Climate Adaptation
Climate change is one of the strongest arguments made for gene editing in agriculture. Rising temperatures, shifting rainfall, and new pest and disease pressures threaten yields of staple crops, and conventional breeding may not keep pace. Researchers are working on edits that improve heat and drought tolerance, disease resistance, and nitrogen use efficiency. Critics argue that diverse farming systems, soil health, and agroecological practices are equally important for climate resilience and that technology alone cannot solve problems rooted in farming systems. Many agricultural scientists see a role for both approaches.
Gene Editing in the Developing World
Because gene editing is relatively inexpensive, it is being used by public research institutions in Africa, Asia, and Latin America to improve local crops, such as disease-resistant bananas, cassava, and rice. Supporters argue this could help smallholder farmers adapt to climate change and pests without relying on multinational seed companies. Concerns include whether farmers will be able to save and share seeds, how regulations will be developed and enforced, and whether benefits will reach the poorest farmers. These issues mirror broader debates about agricultural development discussed in our article on philanthropy and African agriculture.
Gene-Edited Food in Restaurants and Processed Foods
Gene-edited ingredients may first reach many consumers indirectly, through foodservice and processed foods rather than whole produce in grocery stores. Pairwise’s mustard greens, for example, launched through a foodservice distributor serving restaurants. Gene-edited oils, starches, or other ingredients could similarly enter processed foods without prominent labeling. Restaurant foods are exempt from U.S. bioengineered disclosure requirements, so diners would generally not be informed. Consumers who wish to know whether foods contain gene-edited ingredients may need to ask restaurants or manufacturers directly or choose certified organic and non-GMO products.
Food companies that publicly commit to avoiding gene-edited ingredients typically rely on supplier documentation and third-party verification, since testing may not detect small edits. As more products enter the market, these sourcing commitments and certification programs will become more important for shoppers who care about the issue.
How Gene Editing Is Reviewed in Practice
Under USDA’s pre-2020 regulations, which are again in effect, developers can ask the agency whether a particular gene-edited plant falls under its regulations, through a process often called “Am I Regulated.” Plants that do not contain plant pest sequences and do not pose plant pest risks have often been found not to be regulated articles. The FDA’s voluntary consultation process allows developers to share information about the composition and safety of foods from new varieties, including gene-edited ones, and the agency responds with letters summarizing its evaluation. The EPA reviews plants engineered to produce pesticidal substances. Critics argue that voluntary processes and narrow plant-pest definitions leave gaps; supporters argue that products similar to conventionally bred ones do not warrant special scrutiny. The anticipated USDA rule is expected to address how these processes will work going forward.
Developers often publish information about their products and regulatory interactions, and USDA posts its responses publicly. Interested consumers can review these documents to learn what regulators examined for a particular product.
Common Misconceptions
“Gene-edited foods are everywhere already.” Very few have reached consumers, and the first U.S. CRISPR vegetable was withdrawn.
“Gene editing always adds foreign genes.” Many edits change a plant’s own DNA without adding genes from other species.
“Gene-edited foods are unregulated.” Oversight varies by country and product; in the U.S., USDA, FDA, and EPA each have roles, though critics consider them insufficient.
“Organic foods can be gene-edited.” Organic standards in the U.S. and EU exclude gene editing.
“Gene editing is the same as conventional breeding.” Some edits produce results similar to conventional breeding, but the methods differ, and this is the core of the regulatory debate.
Key Facts at a Glance
Gene editing makes targeted changes to a plant’s own DNA, often without adding foreign genes. Only a handful of gene-edited foods have reached consumers worldwide, including a high-GABA tomato and edited fish in Japan; the first U.S. CRISPR vegetable, Pairwise’s mustard greens, was withdrawn by early 2024. USDA’s 2020 SECURE rule was vacated in December 2024, and a replacement rule is expected in 2026. The EU adopted Regulation (EU) 2026/1388 in June 2026, applying from July 2028, under which category 1 gene-edited plants will not require GMO labeling for consumers. Organic standards exclude gene editing in both the U.S. and the EU.
A Balanced View
Gene editing is neither a miracle solution nor an inherent danger. It is a set of tools that can be used to develop traits with real benefits, such as disease resistance, reduced waste, or improved nutrition, as well as traits that mainly serve commercial interests. Its effects depend on which traits are developed, how products are evaluated, who controls the technology, and whether consumers have information and choice. Reasonable people disagree about how much oversight and labeling are appropriate. Following developments in regulation and products, and supporting transparency, allows consumers to form their own judgments as gene-edited foods slowly reach the market.
For consumers, the practical implications in 2026 are modest: few gene-edited foods are available, and those who wish to avoid them can choose certified organic or Non-GMO Project Verified products. The bigger changes lie ahead, as regulators finalize rules and developers bring berries, greens, and other edited crops to market. Watching how labeling and traceability evolve, particularly in the United States, where disclosure rules are under revision, will help shoppers stay informed about what is on their plates.
Readers interested in following these developments can consult the Congressional Research Service’s periodic updates on agricultural biotechnology regulation, USDA’s public records of regulatory determinations, European Commission materials on new genomic techniques, and reporting from both industry groups and organizations critical of gene editing. Reading across perspectives provides the clearest picture of a fast-moving field in which regulations, products, and public attitudes are all still taking shape.
As with any new food technology, informed public debate benefits from clear, accurate information about what gene editing can and cannot do, what has actually reached the market, and how the rules governing it are changing in different parts of the world over the next several years.
Local farmers, seed savers, and food cooperatives can also be useful sources of information about which varieties are being grown nearby and how they were bred.
Checking back periodically on regulatory updates will help readers see how these questions are resolved.
Frequently Asked Questions
Are gene-edited foods GMOs?
It depends on the definition. Under U.S. and new EU rules, many gene-edited plants without foreign DNA are treated differently from traditional GMOs. Organic and Non-GMO Project standards consider them genetically engineered.
Can I buy gene-edited food in the U.S. today?
Very few gene-edited foods are on U.S. shelves. The first CRISPR vegetable was withdrawn in early 2024, and berries and other products are still in development.
Are gene-edited foods labeled?
Many may not require a U.S. bioengineered disclosure. In the EU, category 1 NGT foods will not require GMO labeling once the new regulation applies in 2028.
Are gene-edited foods safe?
Scientific bodies say safety depends on the specific traits, not the method. Products should be evaluated for changes that could affect nutrition, allergens, or toxins.
What happened to USDA’s SECURE rule?
A federal court vacated it in December 2024. USDA reverted to its older regulations and is developing a replacement rule.
References
- Gao C. Genome engineering for crop improvement and future agriculture. Cell. 2021;184(6):1621–1635. PMID 33581057
- National Law Review. District Court Grants Summary Judgment in Part to Plaintiffs, Vacating and Remanding Final SECURE Rule to USDA. December 2024. natlawreview.com
- Congressional Research Service. USDA’s Regulation of Agricultural Biotechnology (IF11573). Updated March 3, 2026. everycrsreport.com
- GMP+ International. New EU regulation on new genomic techniques adopted. 2026. gmpplus.org
- Pairwise. Pairwise Earns USDA Exemption Confirmations for Genomic Edits in Berries. January 2024. pairwise.com
- Canadian Biotechnology Action Network. No GMO Salad Report. June 2025. cban.ca
Last updated: October 4, 2026